Spero Therapeutics's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Spero Therapeutics (NASDAQ:SPRO) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.34. The company's past performance shows a pattern of share price drops following earnings reports, despite beating EPS estimates. The company's shares were trading at $1.48 as of August 08, with a 52-week return of 87.42%.
August 09, 2023 | 5:03 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Spero Therapeutics is expected to report an EPS of $-0.34 in its upcoming earnings. Despite beating EPS estimates in the past, the company's share price has typically dropped post-earnings.
Spero Therapeutics has a history of share price drops following earnings reports, despite beating EPS estimates. This pattern, combined with the estimated negative EPS for the upcoming report, suggests a potential negative short-term impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100